☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
sitryx therapeutics
Sitryx Therapeutics Reports the Initiation of a P-I Study of SIT-011 by Eli Lilly to treat Chronic Autoimmune and Inflammatory Dis...
January 4, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.